NVO Novo Nordisk

FRANKFURT--The following is a summary of analysts' forecasts for Novo Nordisk A/S (NVO) fourth-quarter results, based on a poll of five analysts conducted by Dow Jones Newswires (figures in million danish kroner, EPS, dividend and target price in danish kroner, according to IFRS). Earnings figures are scheduled to be released February 3.

=== 
             Sales:                          -NovoRapid/ 
4th Quarter     -Total  -Victoza   -Levemir      NovoLog 
AVERAGE         28,947     5,183      4,647        5,577 
Prev. Year      24,585     4,010      3,753        4,826 
+/- in %           +18       +29        +24          +16 
 
MEDIAN          28,883     5,194      4,659        5,520 
Maximum         29,306     5,277      4,861        5,810 
Minimum         28,390     5,081      4,470        5,456 
Amount               5         5          5            4 
 
Baader-Helvea   28,883     5,081      4,861           -- 
JP Morgan       28,390     5,100      4,659        5,456 
Morgan Stanley  29,306     5,262      4,485        5,508 
Swedbank        29,305     5,277      4,761        5,810 
UBS             28,851     5,194      4,470        5,532 
 
             Operating       Net        EPS 
4th Quarter     profit    income    diluted 
AVERAGE         11,438     8,526       3.39 
Prev. Year       9,157     6,529       2.51 
+/- in %           +25       +31        +35 
 
MEDIAN          11,305     8,510       3.42 
Maximum         12,017     8,992       3.51 
Minimum         11,124     8,092       3.23 
Amount               4         4          3 
 
Baader-Helvea   11,417     8,747       3.42 
Morgan Stanley  11,124     8,092         -- 
Swedbank        12,017     8,992       3.51 
UBS             11,193     8,272       3.23 
 
         Target price  Rating                  DPS 2015 
AVERAGE        422.20  positive 4    AVERAGE       6.28 
Prev. Quarter  414.42  neutral  1    Prev. Year    5.00 
+/- in %         +1.9  negative 0    +/- in %       +26 
 
MEDIAN         435.00                MEDIAN        6.25 
Maximum        450.00                Maximum       6.61 
Minimum        370.00                Minimum       6.00 
Amount              5                Amount           4 
 
Baader-Helvea  411.00  Buy                           -- 
Barclays       435.00  Overweight                  6.00 
JP Morgan      450.00  Overweight                  6.61 
Swedbank       445.00  Buy                         6.30 
UBS            370.00  Neutral                     6.20 
=== 

Year-earlier figures are as reported by the company.

DJG/err 

(END) Dow Jones Newswires

February 01, 2016 08:35 ET (13:35 GMT)

Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Aug 2024 to Sep 2024

Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Sep 2023 to Sep 2024